Yayın Ağı
SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler
IN VIVO FLUORESCENT IMAGING OF ALLOGENEIC AND XENOGENEIC ISLET GRAFTS FOLLOWING TRANSPLANTATION
IUBMB LIFE
, cilt.61, sa.3, ss.378-379, 2009 (SCI-Expanded)
Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
, cilt.26, sa.2, ss.158-165, 2008 (SCI-Expanded)
The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
, cilt.22, sa.4, ss.307-312, 2004 (SCI-Expanded)
Diğer Dergilerde Yayınlanan Makaleler
Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar
Testing the efficacy of a novel adenovirus mediated TRAIL gene therapy approach for the treatment of patients with Type 1 Diabetes.
Advances in Molecular Medicine, İstanbul, Türkiye, ss.160
Testing the efficacy of a novel adenovirus mediated TRAIL gene therapy approach for the treatment of patients with Type 1 Diabetes.
Advances in Molecular Medicine, İstanbul, Türkiye, ss.160
Efficient adenovirus mediated TRAIL gene delivery into pancreatic islets as a model for the treatment of patients with type 1 diabetes
13th Annual Congress of European Society of Gene Therapy, Çek Cumhuriyeti, ss.74
TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer
13th Annual Congress of European Society of Gene Therapy, Çek Cumhuriyeti, ss.22
Resistance in human foreskin fibroblasts against lipofectamine-aided transfection of CoMiP plasmids
ESGCT 27th Annual Congress in collaboration with SETGyc Meeting, Barcelona, İspanya, 22 - 25 Ekim 2019, cilt.30
HuR knockdown decreases membrane expression of DR5 and reduces apoptosis levels
Conference on Changing the Face of Modern Medicine - Stem Cell and Gene Therapy, Lausanne, İsviçre, 16 - 19 Ekim 2018, cilt.29
Kanserde Gen Tedavisi
V. Nadir Tümörler Sempozyumu, Türkiye, 23 - 25 Şubat 2018
Diyabette Deneysel Gen ve Hücre Tedavisi: TRAIL’xxın Rolü ve Olası Terapötik Potansiyeli
5. Genetik ve Biyomühendislik Günleri, Türkiye, 11 - 12 Şubat 2017
Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185
Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185
Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185
Construction of A lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
EMBO Workshop, Evry, Fransa, 30 Mart - 04 Nisan 2015, ss.185
Comparative efficacy of diet induced obesity in C57BL/6J versus Balb/C mice for gene therapy applications
ESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, cilt.25
Therapeutic efficacy of an HIV-Based Lentivirus Mediated Vasoactive İntestinal Peptide Gene Delivery for Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Therapeutic efficacy of an HIV-Based Lentivirus Mediated Vasoactive İntestinal Peptide Gene Delivery for Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123
Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123
Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123
Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Therapeutic efficacy of an HIV-Based Lentivirus Mediated Vasoactive İntestinal Peptide Gene Delivery for Diabetes
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Comperative efficacy of Diet İnduced Obesity in c57bl/6j versus Balb/C mice for gene Threapy applications
The XXII. Annual ESGCT Congress in collaboration with the NCGCT, Hague, Hollanda, 23 - 26 Ekim 2014
Construction of A Lentiviral Vector Encoding Human Vasoactive Intestinal Peptide for Diabetes Treatment
Human Gene TherapyESGCT and NVGCT Collaborative Congress, The Hague, Hollanda, 23 - 26 Ekim 2014, ss.123
Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138
Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138
Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138
Pancreatic expression profiles of vasoactive intestinal peptide and its receptors in mouse model of type 2 diabetes
Collaborative Congress of the European-Society-for-Gene-and-Cell-Therapy and the Spanish Society for Gene and Cell Therapy, Madrid, İspanya, 25 - 28 Ekim 2013, cilt.24, sa.12, ss.138
Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258
Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258
Downregulation of Vasoactive Intestinal Peptide Expression in Type 2 Diabetes
Congress of American Diabetes Association, Chicago, Amerika Birleşik Devletleri, 21 - 25 Haziran 2013, cilt.62, ss.2258
Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20
Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20
Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20
Tip 2 diyabet deney hayvan modelinde diyabet induksiyonu adaciklarda vazoaktif intestinal peptid azalimiyla korelasyon gosterdi
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.20
Diyabette Vazoaktif Intestinal Peptidin terapotik rolü
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.12
Diyabette Vazoaktif Intestinal Peptidin terapotik rolü
49. Ulusal Diyabet Kongresi, Antalya, Türkiye, 17 - 21 Nisan 2013, ss.12
Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79
Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79
Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European Society of Gene and Cell Therapy/French Society of Cell and Gene Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23, sa.10, ss.78-79
Diabetogenic response to streptozotocin varies among NOD and NOR mice
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23
Generation of a cost effective and a practical animal model for Type 2 Diabetes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23
Potential Therapeutic Role of Vasoactive Intestinal Peptide in Diabetes
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23
Pancreatic acinar cells respond differentially to diabetic agents Streptozotocin and Cyclophosphamide
Collaborative Congress of the European-Society-of-Gene-and-Cell-Therapy/French-Society-of-Cell-and-Gene-Therapy, Versailles, Fransa, 25 - 29 Ekim 2012, cilt.23
NOD farelerde streptozotosin veye siklofosfamid ile hizlandirilmis Tip 1 Diyabet gelisim surecinde pankreatik asinar hucrelerde farkli TRAIL ligand ve reseptor paternleri
XII Ulusal Tibbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 27 - 30 Ekim 2011, ss.187
“In Vivo Fluorescence Tracing Of Xenogeneic Islet Graft Survival In Type 1 Diabetes
9th National Congress of Medical Genetics, İstanbul, Türkiye, 1 - 05 Aralık 2010, cilt.0, sa.0, ss.1-2
Distinctive expression profiles of trail and trail receptors in patients with endometrial carcinoma
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1462
Spontaneous type 1 diabetes in NOD mice is related to an increase in DcR1 expression
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1447-1448
Trail profile of synoviocytes and peripheral blood lymphocytes of rheumatoid arthritis patients
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1448-1449
Endometrial hyperplasia features distinctive trail and trail receptor expression profiles
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1462-1463
In vivo fluorescence imaging of xenogeneic islet graft survival
18th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Milan, İtalya, 22 - 25 Ekim 2010, cilt.21, ss.1451
Non-obese diabetic (NOD) farelerde streptozotosin veya siklofosfamid ile indüklenen diyabette T1D’in moleküler patogenezinin aydınlatılmasına yönelik bulgular
46. Ulusal Diyabet Kongresi, Antalya, Türkiye, 12 - 16 Mayıs 2010, ss.6
Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats
17th Annual Congress of the European Society of Gene & Cell Therapy, Hannover, Almanya, 21 - 25 Kasım 2009, ss.1471-1472
Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats
17th Annual Congress of the European Society of Gene & Cell Therapy, Hannover, Almanya, 21 - 25 Kasım 2009, ss.1471-1472
Tracing of the fate of allogeneic islet grafts via CCD camera
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1479
In vivo fluorescence imaging as a method to assess pancreatic islet xenograft failure
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1479
Alterations in TRAIL ligand and receptor expression profiles in CY-accelerated type 1 diabetes in NOD mice
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1483
Differential levels of TRAIL ligand and receptor expressions in STZ-induced T1 diabetes in non-obese diabetic (NOD) mice
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1483
Monitoring of systemic delivery of adenovirus mediated EGFP transgene expression in mice using fluorescence imaging
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1507
Adenovirus mediated TRAIL gene therapy approach provides sustained insulin expression in STZ-induced diabetic rats
Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, Hannover, Almanya, 21 - 25 Kasım 2009, cilt.20, ss.1471-1472
Tip 1 diyabette alloimmune mononüklear hücre infiltrasyonun gen tedavisiyle baskılanması fonksiyonel adacık-graft ömrünü uzatır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.56
Diyabetik farelere sıçan pankreatik adacıklarının ksenotransplantasyonu normoglisemi sağlamaktadır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.76
Diyabetik farelere sıçan pankreatik adacıklarının ksenotransplantasyonu normoglisemi sağlamaktadır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.76
Tip 1 diyabette alloimmune mononüklear hücre infiltrasyonun gen tedavisiyle baskılanması fonksiyonel adacık-graft ömrünü uzatır
45. Ulusal Diyabet Kongresi, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.56
A novel gene therapy strategy involving immune-modulation relinquished lymphocyte infiltration into islet grafted sites in STZ induced diabetic rats
11th European Congress of Endocrinology, İstanbul, Türkiye, 25 - 29 Nisan 2009, ss.1
A novel gene therapy strategy involving immune-modulation relinquished lymphocyte infiltration into islet grafted sites in STZ induced diabetic rats
11th European Congress of Endocrinology, İstanbul, Türkiye, 25 - 29 Nisan 2009, ss.1
Pancreatic ductal adenocarcinoma (PDAC) patients reveal elevated TRAIL Death Receptor-4 (DR4) and decoy receptor-2 (DcR2) expression correlated with significant cell death
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1104
Prolonged normoglycemia in STZ-induced diabetic rats transplanted with Adenovirus-mediated human TRAIL gene (Ad5hTRAIL) infected islets
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1119-1120
In vivo imaging to detect the duration of adenovirus mediated EGFP transgene expression in allogeneic islet grafts
16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Brugge, Belçika, 13 - 16 Kasım 2008, cilt.19, ss.1121-1122
Adenovirus-mediated human TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets provides prolonged normoglycemia in STZ-induced diabetic rats
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 - 01 Mayıs 2008, ss.10
Gene therapy application scenarios to prolong islet-graft survival in patients with type 1 diabetes
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.5
Adenovirus-mediated human TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets provides prolonged normoglycemia in STZ-induced diabetic rats
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 - 01 Mayıs 2008, ss.10
Gene therapy mediated apoptosis inducing approaches employing Ad5hTRAIL and a DCR2 siRNA strategy in lung cancer patients
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.3
Gene therapy application scenarios to prolong islet-graft survival in patients with type 1 diabetes
3. Klinik Pratikte Kok Hucre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 29 Mayıs - 01 Haziran 2008, ss.5
Pankreatik adaciklara adenovirus aracili insan TRAIL geni (Ad5hTRAIL) aktarimi STZ induklemeli diyabetik sicanlarda uzun sureli normoglisemi saglar
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.1
Pankreatik adaciklara adenovirus aracili insan TRAIL geni (Ad5hTRAIL) aktarimi STZ induklemeli diyabetik sicanlarda uzun sureli normoglisemi saglar
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.1
Tip 1 diyabet hastalarinda gerceklestirilen adacik naklinde graft sagkalimini uzatabilecek gen tedavi senaryolari
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.3
Tip 1 diyabet hastalarinda gerceklestirilen adacik naklinde graft sagkalimini uzatabilecek gen tedavi senaryolari
44. Ulusal Diyabet Kongresi, Antalya, Türkiye, 28 Mayıs - 01 Haziran 2008, ss.3
TRAILING from molecular diagnostics to prostate cancer gene therapy
XIX Ulusal İmmunoloji Kongresi, Antalya, Türkiye, 21 - 24 Kasım 2007, ss.33
TRAILING from molecular diagnostics to prostate cancer gene therapy
XIX Ulusal İmmunoloji Kongresi, Antalya, Türkiye, 21 - 24 Kasım 2007, ss.33
Adenovirus vectors efficiently deliver TRAIL into pancreatic islets without generating cytotoxic effects
15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Rotterdam, Hollanda, 27 - 30 Ekim 2007, cilt.18, ss.1074
High endogenous TRAIL expression levels in human pancreas is correlated with increased cell death
15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Rotterdam, Hollanda, 27 - 30 Ekim 2007, cilt.18, ss.1074-1075
Comparative analysis of TRAIL and its receptor expression profiles in synoviocytes versus peripheral lymphocytes of patients with rheumatoid arthritis
15th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, Rotterdam, Hollanda, 27 - 30 Ekim 2007, cilt.18, ss.1091-1092
Expression profile of TRAIL and its receptors in breast cancer patients with invasive ductal carcinoma
ECCO 14 The European Cancer Conference, Barcelona, İspanya, 23 - 27 Eylül 2007, ss.225-226
Tip 1 diyabet gelişiminde rol alan TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptörlerinin normal insan pankreasindaki sentez profili ve artan apoptozis ile korelasyonu
X. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 6 - 09 Eylül 2007, ss.112
Tip 1 diyabet gelişiminde rol alan TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptörlerinin normal insan pankreasindaki sentez profili ve artan apoptozis ile korelasyonu
X. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 6 - 09 Eylül 2007, ss.232
Tip 1 diyabet gelişiminde rol alan TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptörlerinin normal insan pankreasindaki sentez profili ve artan apoptozis ile korelasyonu
X. Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Türkiye, 6 - 09 Eylül 2007, ss.112
Tip 1 diyabette ölümcül ligant aracılı gen tedavi modelinin moleküler etki mekanizması.
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.45
Yokluğu Tip 1 diyabetle ilişkilendirilmis TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptorlerinin normal insan pankreasindaki sentez profili
43. ULUSAL DİYABET KONGRESİ, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.66
Tip 1 diyabette ölümcül ligant aracılı gen tedavi modelinin moleküler etki mekanizması.
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.45
Tip 1 diyabetli hastalarda kullanılacak etkin bir tedavi modelinin geliştirilmesi maksadıyla pankreatik adacıklara adenovirus aracılı TRAİL geni aktarımı
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.51
Tip 1 diyabetli hastalarda kullanılacak etkin bir tedavi modelinin geliştirilmesi maksadıyla pankreatik adacıklara adenovirus aracılı TRAİL geni aktarımı
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.51
Yokluğu Tip 1 diyabetle ilişkilendirilmis TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptorlerinin normal insan pankreasindaki sentez profili
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.54
Yokluğu Tip 1 diyabetle ilişkilendirilmis TNF-Related Apoptosis Inducing Ligand (TRAIL) ölümcül ve yalancı reseptorlerinin normal insan pankreasindaki sentez profili
43. Ulusal Diyabet Kongresi, Antalya, Türkiye, 9 - 13 Mayıs 2007, ss.54
A DcR2 siRNA strategy employing three different siRNA constructs in combination defeats adenovirus transferred TRAIL resistance in lung cancer cells
XIV Annual Congress of the European Society of Gene Therapy, Atina, Yunanistan, 9 - 12 Kasım 2006, ss.103
Differential expression of trail and its receptors in patients with prostate carcinoma
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.133
Adenovirus delivery of TRAIL effectively destroys synoviocytes of patients with rheumatoid arthritis
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.134
A DCR2 siRNA approach defeats trail resistance in lung cancer cells
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.133
Adenovirus mediated TRAIL gene delivery as a model for the treatment of patients with diabetes
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Türkiye, 24 - 29 Haziran 2006, cilt.273, ss.206
Tip 1 diyabetli hastalar için geliştirilen pankreatik adacık transplantasyonunda adenovirus aracılı TRAİL gen transferinin etkinliği
IX. Ulusal Tıbbi Biyoloji Kongresi, Manisa, Türkiye, 24 - 27 Kasım 2005, ss.66
DcR2 siRNA yaklaşımı A549 akciğer kanser hücrelerini adenovirus aracılı TRAİL transferine duyarlı kılar
IX. Ulusal Tıbbi Biyoloji Kongresi, Manisa, Türkiye, 24 - 27 Kasım 2005, ss.5
Tip 1 diyabetli hastalar için geliştirilen pankreatik adacık transplantasyonunda adenovirus aracılı TRAİL gen transferinin etkinliği
IX. Ulusal Tıbbi Biyoloji Kongresi, Manisa, Türkiye, 24 - 27 Kasım 2005, ss.66
TRAIL ligand and receptor expressions are differentially upregulated in prostate carcinoma patients: a significant issue for gene therapy of advanced prostate cancer
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.22
A DcR2 siRNA approach overcomes TRAIL resistance in A549 lung cancer cells
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.172
Surface TRAIL decoy receptor-4 expression constitutes a resistance to adenovirus delivery of TRAIL in MCF7 breast cancer cells
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.15
Efficient adenovirus mediated TRAIL gene delivery into pancreatic islets as a model for the treatment of patients with type 1 diabetes
13th Annual Congress of European Society of Gene Therapy, Prague, Çek Cumhuriyeti, 29 Eylül - 01 Ekim 2005, ss.74
Testing the efficacy of a novel adenovirus mediated TRAIL gene therapy approach for the treatment of patients with Type 1 Diabetes
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.160
A novel death ligand mediated gene therapy approach for patients with lung cancer
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.162
Surface TRAIL Receptor-4 expression correlates with TRAIL resistance in breast cancer cells
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.164
Surface TRAIL Receptor-4 expression correlates with TRAIL resistance in breast cancer cells
Advances in Molecular Medicine, İstanbul, Türkiye, 3 - 05 Eylül 2005, ss.164
Therapeutic effect of recombinant adenovirus mediated TRAIL gene therapy method in Lung Cancer
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.22
Advanced prostate cancer cells display differential NF-kB activation pattern which is the primary determinant of TRAIL resistance
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.19
Anti HIV drug PDTC genetoxic agents synergistically activate Adeno Associated Virus Type-2 endocytosis and transduction
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.56
Advanced prostate cancer cells display differential NF-kB activation pattern which is the primary determinant of TRAIL resistance
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.19
Resistance to Adenovirus mediated TRAIL gene therapy in breast cancer cells is eliminated by the expression of dominant negative IKKb
12th Annual Congress of European Society of Gene Therapy, Tampere, Finlandiya, 4 - 07 Kasım 2004, ss.20
Akciğer kanserinde recombinant adenovirus aracılı TRAİL gen tedavi metodunun terapötik etkisi
1. Ulusal Klinik Pratikde Kök Hücre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 7 - 09 Mayıs 2004, ss.128
Hücre içi anti-apoptotik yolun bloke edilmesi meme kanserini adenovirus aracılı TRAİL gen tedavi metoduna karşı duyarlı hale getirdi
1. Ulusal Klinik Pratikde Kök Hücre ve Gen Tedavisi Kongresi, İstanbul, Türkiye, 7 - 09 Mayıs 2004, ss.127
İleri ever prostat kanserinde NFkB yolunun bloke edilmesi TRAİL dirençliliğini kırar
VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.27
İleri ever meme kanserinin adenovirus aracılı TRAİL gen tedavi metoduna duyarlılaştırma yöntemleri
VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.4
İleri ever prostat kanserinde NFkB yolunun bloke edilmesi TRAİL dirençliliğini kırar
VI. Ulusal Prenatal Tanı ve Tıbbi Genetik Kongresi, Antalya, Türkiye, 21 - 24 Nisan 2004, ss.27
PTENin Gleson skoru ve PSAya kıyasla prostat kanserindeki prognostik değerinin belirlenmesi.
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.5
Adenovirus aracılı TRAİL geni aktarımının prostat karsinomanın farklı evreleri üzerindeki etkinliği ve prostat kanserli hastalarda TRAİLe olan direnci kırmak için yeni gen tedavi metotlarının geliştirilmesi
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.3
Adenovirus aracılı TRAİL geni aktarımının prostat karsinomanın farklı evreleri üzerindeki etkinliği ve prostat kanserli hastalarda TRAİLe olan direnci kırmak için yeni gen tedavi metotlarının geliştirilmesi
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.3
PTENin Gleson skoru ve PSAya kıyasla prostat kanserindeki prognostik değerinin belirlenmesi.
8. Ulusal Tıbbi Biyoloji Kongresi, Adana, Türkiye, 14 - 17 Ekim 2003, ss.5
Kitap & Kitap Bölümleri
Bilirkişi Raporları
